StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / junevity.com

Junevity

Junevity (junevity.com): 3 changes recorded in its website history since May 2024. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeCell Reprogramming with siRNA
    AfterReset gene networks to reverse disease, starting with siRNA for obesity

    Observed on the company’s website; business claims are not independently verified.

  2. HeadlineBetween and
    BeforeCELL RESET FOR LONGEVITY
    AfterCell Reprogramming with siRNA

    Observed on the company’s website; business claims are not independently verified.

  3. MessagingBetween and
    BeforeTRANSCRIPTION FACTORS
    AfterCELL RESET FOR LONGEVITY

    Classifier interpretation of website text.

First recorded website

Observed 28 May 2024

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

TRANSCRIPTION FACTORS

Junevity's mission is to rewind diseases of aging by targeting transcription factors with novel medicines.

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. Seen November 2026 · 1 capture · latest observed messagingReset gene networks to reverse disease, starting with siRNA for obesity

    Junevity is a biotechnology company resetting gene networks with siRNA therapeutics to reverse disease.

    This wording observed 6 November 2026.

  2. Seen December 2025 · 1 captureCell Reprogramming with siRNA

    Junevity is pioneering cell reprogramming with siRNA to extend human healthspan and lifespan.

    This wording observed 3 December 2025.

  3. Seen January 2025 · 1 captureCELL RESET FOR LONGEVITY

    Junevity develops novel therapeutics to rewind metabolic disease.

    This wording observed 12 January 2025.

  4. Seen May 2024 · 1 captureTRANSCRIPTION FACTORS

    Junevity's mission is to rewind diseases of aging by targeting transcription factors with novel medicines.

    This wording observed 28 May 2024.

Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Junevity updates homepage focus on siRNA and obesity

Junevity’s homepage messaging has shifted over time from transcription factors and longevity toward cell reprogramming with siRNA and a stated focus on obesity. Recent wording emphasizes resetting gene networks to reverse disease, starting with siRNA for obesity.

  • Between May 2024 and January 2025, Junevity changed its homepage headline from “TRANSCRIPTION FACTORS” to “CELL RESET FOR LONGEVITY”, which a classifier read as a repositioning. [1]
  • Reading: This change between May 2024 and January 2025 suggests Junevity may have shifted emphasis toward longevity-focused cell reset. [1]
  • Between January 2025 and December 2025, Junevity changed its homepage headline from “CELL RESET FOR LONGEVITY” to “Cell Reprogramming with siRNA”. [2]
  • Between December 2025 and November 2026, Junevity changed its homepage headline from “Cell Reprogramming with siRNA” to “Reset gene networks to reverse disease, starting with siRNA for obesity”. [3]

Cite this record

StartupHistory, “Junevity” company record, https://startuphistory.org/c/junevity.com

Machine-readable: /c/junevity.com.json. How changes are found: method.